Generation and purification of iPSC-derived cardiomyocytes for clinical applications
Abstract Background Over the past decade, the field of cell therapy has rapidly expanded with the aim to replace and repair damaged cells and/or tissue. Depending on the disease many different cell types can be used as part of such a therapy. Here we focused on the potential treatment of myocardial...
Saved in:
| Main Authors: | M. Generali, D. Kehl, D. Meier, D. Zorndt, K. Atrott, H. Saito, MY. Emmert, SP. Hoerstrup |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04319-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomal miR-202-5p derived from iPSC-MSCs protects against myocardial infarction through inhibition of cardiomyocyte pyroptosis
by: Jiaqi Chen, et al.
Published: (2025-06-01) -
Single-cell RNA sequencing reveals key regulators and differentiation trajectory of iPSC-derived cardiomyocytes
by: Lu Li, et al.
Published: (2024-11-01) -
Machine learning approach to study drug effects and identification of signals from symptomatic and asymptomatic mutation carries using iPSC-derived cardiomyocytes
by: Martti Juhola, et al.
Published: (2025-01-01) -
iPSC-Derived Biological Pacemaker—From Bench to Bedside
by: Quan Duy Vo, et al.
Published: (2024-12-01) -
Electronic and regular cigarettes induce transcriptional and physiological changes in cardiomyocytes
by: Hesham Basma, et al.
Published: (2025-07-01)